Pages that link to "Q24648295"
Jump to navigation
Jump to search
The following pages link to The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/myocyte enhancer factor 2C pathway (Q24648295):
Displaying 50 items.
- High glucose suppresses human islet insulin biosynthesis by inducing miR-133a leading to decreased polypyrimidine tract binding protein-expression (Q21136357) (← links)
- Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism (Q26739857) (← links)
- MicroRNAs as pharmacological targets in diabetes (Q26824024) (← links)
- Human genetics of diabetic vascular complications (Q27000709) (← links)
- Glucose tolerance is associated with differential expression of microRNAs in skeletal muscle: results from studies of twins with and without type 2 diabetes (Q28117792) (← links)
- MicroRNAome comparison between intramuscular and subcutaneous vascular stem cell adipogenesis (Q31101574) (← links)
- Epithelial SCAP/INSIG/SREBP signaling regulates multiple biological processes during perinatal lung maturation (Q33577973) (← links)
- Direct regulation of the proglucagon gene by insulin, leptin, and cAMP in embryonic versus adult hypothalamic neurons. (Q33636368) (← links)
- Alteration of microRNA expression correlates to fatty acid-mediated insulin resistance in mouse myoblasts. (Q34156501) (← links)
- An antagomir to microRNA Let7f promotes neuroprotection in an ischemic stroke model (Q34185984) (← links)
- Postprandial regulation of hepatic microRNAs predicted to target the insulin pathway in rainbow trout. (Q34305614) (← links)
- Tissue-specific regulation of mouse MicroRNA genes in endoderm-derived tissues (Q34513855) (← links)
- Endometrial exosomes/microvesicles in the uterine microenvironment: a new paradigm for embryo-endometrial cross talk at implantation (Q34629669) (← links)
- Simultaneous miRNA and mRNA transcriptome profiling of human myoblasts reveals a novel set of myogenic differentiation-associated miRNAs and their target genes (Q34676929) (← links)
- Integrative analysis of porcine microRNAome during skeletal muscle development (Q34988387) (← links)
- MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications (Q35063263) (← links)
- Hormone replacement therapy enhances IGF-1 signaling in skeletal muscle by diminishing miR-182 and miR-223 expressions: a study on postmenopausal monozygotic twin pairs (Q35093102) (← links)
- Effect of vitrification on the microRNA transcriptome in mouse blastocysts (Q35327021) (← links)
- The emerging role of microRNAs in drug responses (Q35599477) (← links)
- Circulating MiRNAs of 'Asian Indian Phenotype' Identified in Subjects with Impaired Glucose Tolerance and Patients with Type 2 Diabetes (Q35645131) (← links)
- Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance (Q36322951) (← links)
- The Ups and Downs of Insulin Resistance and Type 2 Diabetes: Lessons from Genomic Analyses in Humans (Q36642598) (← links)
- miR-200a regulates Rheb-mediated amelioration of insulin resistance after duodenal-jejunal bypass (Q37151171) (← links)
- Defective regulation of microRNA target genes in myoblasts from facioscapulohumeral dystrophy patients (Q37368598) (← links)
- Making sense in antisense: therapeutic potential of noncoding RNAs in diabetes-induced vascular dysfunction. (Q37393027) (← links)
- Essential amino acids increase microRNA-499, -208b, and -23a and downregulate myostatin and myocyte enhancer factor 2C mRNA expression in human skeletal muscle (Q37421218) (← links)
- Exercise mediated protection of diabetic heart through modulation of microRNA mediated molecular pathways (Q37586770) (← links)
- Myotube-derived exosomal miRNAs downregulate Sirtuin1 in myoblasts during muscle cell differentiation (Q37587033) (← links)
- A Systematic Study of Dysregulated MicroRNA in Type 2 Diabetes Mellitus (Q37728970) (← links)
- MicroRNAs in skeletal muscle: their role and regulation in development, disease and function. (Q37781219) (← links)
- Diabetes mellitus, a microRNA-related disease? (Q37855088) (← links)
- Circulating microRNAs as novel biomarkers for diabetes mellitus (Q38102924) (← links)
- Molecular mechanisms of muscle plasticity with exercise (Q38111713) (← links)
- MicroRNA in skeletal muscle development, growth, atrophy, and disease (Q38212617) (← links)
- Insulin resistance associated genes and miRNAs (Q38225286) (← links)
- Human genetics of diabetic retinopathy (Q38247113) (← links)
- Noncoding RNAs as epigenetic mediators of skeletal muscle regeneration (Q38284580) (← links)
- Human genetics of diabetic nephropathy (Q38320756) (← links)
- microRNAs with different functions and roles in disease development and as potential biomarkers of diabetes: progress and challenges (Q38375953) (← links)
- Beyond the Protein-Coding Sequence: Noncoding RNAs in the Pathogenesis of Type 2 Diabetes (Q38727328) (← links)
- Exosome-like vesicles released from lipid-induced insulin-resistant muscles modulate gene expression and proliferation of beta recipient cells in mice (Q38795932) (← links)
- Hierarchical Feature Selection Incorporating Known and Novel Biological Information: Identifying Genomic Features Related to Prostate Cancer Recurrence (Q38824071) (← links)
- The potential of endurance exercise-derived exosomes to treat metabolic diseases. (Q38845636) (← links)
- Regulation of Skeletal Muscle by microRNAs. (Q38878232) (← links)
- Biological roles of microRNAs in the control of insulin secretion and action (Q38999205) (← links)
- Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus (Q39032370) (← links)
- miR-186 inhibits muscle cell differentiation through myogenin regulation (Q39037772) (← links)
- Intersections of post-transcriptional gene regulatory mechanisms with intermediary metabolism (Q39088851) (← links)
- MicroRNA expression profile during adipogenic differentiation in mouse embryonic stem cells (Q39606114) (← links)
- miR-133a Promotes TRAIL Resistance in Glioblastoma via Suppressing Death Receptor 5 and Activating NF-κB Signaling. (Q41440890) (← links)